top of page


Integrating equitable access conditions into antimicrobial R&D incentive mechanisms
During the 2024 UN High-Level Meeting on Antimicrobial Resistance (AMR), stakeholders set an ambitious goal to achieve a 10% reduction in...

Aanika Dalal
Jun 211 min read


Why the EU’s Antibiotic Revenue Guarantee Scheme Stalled – and how to fix it
Bringing life-saving antibiotics to market is a paradox: doctors depend on them, yet are trained to use them sparingly. This creates a...

David McKinney
Mar 275 min read


New Science - New Partnerships for Antimicrobial Drug Discovery
The antimicrobial discovery and development ecosystem faces many challenges, including a loss of experienced talent, difficulty...

David McKinney
Dec 12, 20241 min read


G7 Compliance Assessments
Over the past several months, ARMoR has worked alongside the G7 Research Group at the University of Toronto to assess the compliance of...

Aanika Dalal
Oct 4, 20241 min read


Strengthening National Action Plans for AMR: The Case for Commitments to Pull Incentives
Antimicrobial resistance (AMR) is a severe global health threat. In the EU alone, there were an estimated 58,300 fatalities directly...

ARMoR
Aug 14, 20245 min read


Tackling the antimicrobial Research and Development and access crisis: An overview
This is a cross-post from a guest article written for the European Public Health Alliance . The importance of antimicrobial medicines in...

David McKinney
Jul 23, 20244 min read


Introducing ARMoR - Alliance for Reducing Microbial Resistance
TL;DR: Â ARMoR, or the Alliance for Reducing Microbial Resistance, is a Charity Entrepreneurship incubated advocacy organisation combating...

ARMoR
Oct 8, 20237 min read
bottom of page